New Paper Calls for Adult Vaccine Quality Measures

Michael Hodin Joins Former U.S. Surgeon General and Other Experts as Co-Author of Adult Vaccines Access Coalition Report

NEW YORK (August 1, 2016) – In a new white paper, The Value and Imperative of Quality Measures for Adult Vaccines, renowned experts across health, aging and immunization, including Michael Hodin, CEO of the Global Coalition on Aging, explain how vaccine quality measures can prevent illness and death, reduce caregiving demands, save unnecessary healthcare spending, and set the foundation for healthy aging. The paper urges that adult vaccination quality measures should be included in the implementation of two national measure developments underway in the United States: the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA) and the Core Quality Measures Collaborative.

Every year, more than 40,000 U.S. adults are hospitalized or die due to vaccine-preventable diseases. In addition, vaccine-preventable diseases cost the U.S. billions each year. Nevertheless, adult vaccination rates remain far below national targets. Improving rates of adult vaccination is a national imperative. Higher vaccination rates among adults reduce clinic visits, the rate of hospitalizations, and the incidence of long-term disability. Higher vaccination rates also save money by preventing lost productivity from employee sick days.

Hodin’s co-authors include James Appleby, RPH, MPH, Executive Director and CEO, The Gerontological Society of America; David Satcher, MD, PhD, Former Surgeon General of the United States; William Schaffner, MD, Medical Director, National Foundation for Infectious Diseases, Professor of Preventive Medicine, Department of Health Policy, Vanderbilt University School of Medicine; and LJ Tan, PhD, Chief Strategy Officer, Immunization Action Coalition.  Eleanor Perfetto, PhD, Professor of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, also contributed to the report.

“Older adults have a great deal to contribute to society and the economy, but they can only do so if they are able to remain healthy and active,” said Hodin. “With 78 million of us reaching the age of 65, we must increase awareness and uptake of vaccines for older adults. Adult vaccines are becoming an increasingly important and cost-effective means to safeguard the health, wellbeing, and productivity of this fast-growing segment of the U.S. population and the communities in which they live.”

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.